LAROCCA JOHN (SVP, General Counsel & Secry) received a stock award from Y-MABS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/22/2025ACC: 0001415889-25-001874
Officer· SVP, General Counsel & Secry
Since Jan 2025
+64.40K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
64.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.50K
Price / share
—
Trade value
—
% of position
New position
1/17/2025
0.00→21.50K
Total
Net shares
+21.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2025 | A · Award | +21.50K | — | — | New position | 0.00 | 21.50K |
| Total | +21.50K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
42.90K shares
Shares
+42.90K
Strike price
6.16
Held after
42.90K
Exercisable
—
1/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock42.90K shares | 1/17/2025 | A · Award | +42.90K | 6.16 | — | 42.90K |